HRT FINANCIAL LP

Position in LQDA — Liquidia Corp

CIK 1475597 NEW YORK, NY

Position in LQDA

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$3,271,567

-$2,528,823 QoQ

Shares Held

86,687

-48.5% QoQ

Ownership

0.097%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $86,437,876 across 27 Drug Manufacturers - Specialty & Generic names. LQDA ranks #6 (3.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	66,842	$39,635,969
2	HLN	Haleon plc	1,100,190	$11,012,901
3	HIMS	Hims & Hers Health, Inc.	284,622	$5,908,752
4	TEVA	Teva Pharmaceutical Industries Ltd	140,222	$4,223,486
5	NBIX	Neurocrine Biosciences Inc	26,404	$3,478,462
6	LQDA	Liquidia Corp This page	86,687	$3,271,567
7	ALKS	Alkermes plc.	81,989	$2,899,131
8	TAK	Takeda Pharmaceutical Co Ltd	126,074	$2,334,890

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,271,567	86,687	-48.5%	Shares	Defined	2026-05-14
2025-12-31	$5,800,390	168,176	+130.3%	Shares	Defined	2026-02-12
2025-06-30	$910,003	73,034	+74.1%	Shares	Defined	2025-08-14
2024-09-30	$419,450	41,945	+285.3%	Shares	Defined	2024-11-12
2024-06-30	$130,632	10,886	-88.6%	Shares	Defined	2024-08-12
2023-06-30	$750,609	95,619	+20.2%	Shares	Defined	2023-08-11
2023-03-31	$549,517	79,525	+52.6%	Shares	Defined	2023-05-12
2021-09-30	$143,809	52,105	+59.8%	Shares	Defined	2021-11-15
2021-06-30	$93,261	32,609	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.